ESC 365 - Improving kidney disease and preventing HF in T2D-associated CKD with finerenone

HFA Premium Access

Improving kidney disease and preventing HF in T2D-associated CKD with finerenone

Session: Protecting the heart and kidneys: the role of finerenone

Topic: Treatment

Speaker: Professor P. Rossing (Herlev, DK)

Sponsored by Bayer

Event: Heart Failure 2024

Congress Presentation

Add to my library

About the speaker

Professor Peter Rossing

Steno Diabetes Center, Copenhagen, Herlev (Denmark)

5 presentations

0 follower

4 more presentations in this session

Welcome and introduction

Speaker: Professor S. Solomon (Boston, US)

The heart and kidney interlink and its role in driving CKD and heart failure

Speaker: Professor B. Bozkurt (Houston, US)

Investigating the role of finerenone in the care of patients with heart failure

Speaker: Professor J. Butler (Dallas, US) Professor S. Solomon (Boston, US)

Q&A and close

Speaker: Professor S. Solomon (Boston, US)

Access the full session

Protecting the heart and kidneys: the role of finerenone

Speakers: Professor P. Rossing, Professor S. Solomon, Professor B. Bozkurt, Professor J. Butler, Professor S. Solomon...

About the event

Heart Failure 2024

11 May - 14 May 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources